Loading clinical trials...

Comparison of Safety and Efficiency of 20w and 30w Holmium Laser Device in Management of 2-3 cm Diameter Kidney Stones With Retrograde Intrarenal Surgery | Clinical Trials | Clareo Health

UNKNOWNPHASE4

Comparison of Safety and Efficiency of 20w and 30w Holmium Laser Device in Management of 2-3 cm Diameter Kidney Stones With Retrograde Intrarenal Surgery

NCT02443909•Diskapi Teaching and Research Hospital

View on ClinicalTrials.gov

Summary

To compare safety and efficiency of 20w 30w holmium laser device in treatment of 2-3 cm diameter kidney stones with Retrograde Intrarenal Surgery (RIRS).

Eligibility

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patients who have 2-3 cm kidney stones
•patients who are between 18-90 years old

Exclusion Criteria

•patients who have congenital urogenital abnormalities
•patients who have previous surgery history for urinary stones

Locations (1)

S.B.Dıskapı Yıldırım Beyazıt Training and Research Hospital

Ankara, Turkey (Türkiye)

Key Dates

Start Date

January 1, 2015

Primary Completion Date

December 1, 2016

Completion Date

January 1, 2017

Last Updated

May 14, 2015

Enrollment

ESTIMATED participants

Conditions

Nephrolithiasis

Interventions

Retrograde Intrarenal Surgery

PROCEDURE

Retrograde Intrarenal Surgery

PROCEDURE

Retrograde Intrarenal Surgery

PROCEDURE

Holmium laser device

DEVICE

Contacts

Nihat Karakoyunlu, MD

CONTACT

00905324747134 nkarakoyunlu@gmail.com

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

NCT04669886

NephrolithiasisUrosepsis

View study

RECRUITINGNA

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

NCT06576661

Kidney StoneNephrolithiasis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 14, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparison of Safety and Efficiency of 20w and 30w Holmium Laser Device in Management of 2-3 cm Diameter Kidney Stones With Retrograde Intrarenal Surgery

Inclusion Criteria

Exclusion Criteria

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

Bendable Suction Ureteral Access Sheath Versus Conventional Ureteral Access Sheath in Management of Renal Stones Using Flexible Ureteroscopy

National Registry of Rare Kidney Diseases

Dual-process Mechanisms of Action for sipIT Intervention Effects in Patients With Urolithiasis

HoYAG vs TFL in miniPCNL With ClearPetra